The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Thanks BJ
particularly like the last bit
'We don’t have any concerns over the management of our cash flow as we grow, particularly given that the substantial revenue growth we expect to see in the new financial year will naturally have a major impact on our cash generation.'
No way would a CEO ( particularly someone as grounded as CK) say this publicly if orders were not all but nailed on
Yep and orders could come this week ;)
640k late trade @ 93 popped up
They do not stack up , this needs investigating .
Millions of quick Covid tests to be made by British firms
Millions of rapid Covid-19 tests are to be manufactured by British firms as the Government ramps up its plans to encourage people without symptoms to get themselves checked for the virus.
Two firms have signed deals with the Department of Health and Social Care (DHSC) to make lateral flow tests.
The companies will be able to make two million rapid turnaround tests every week by the end of May, officials said.
It comes as the Government is encouraging more and more people to take tests when they do not have symptoms.
It is hoped that by finding cases among people who do not have symptoms, it will help stem the spread of the virus.
DHSC said that it has agreed contracts with Omega Diagnostics, headquartered in Alva in Scotland, and Global Access Diagnostics, based in Thurleigh, Bedfordshire, to provide manufacturing capacity for up to 200 million tests - and creating around 470 jobs.
The difference in tone is stark . The RNS must be Nomad influenced. They are supposed to be independent, however I think some I.I's are exerting undue influence.
I agree I.I.'s obviously trying to buy into the Co ( and we need them), hence all the talk of price held under £1.00. ODX and the I.I. 's do not want this to go ballistic until they are in. Not long now, great future here
RNS Number : 7747Q
Omega Diagnostics Group PLC
02 March 2021
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Contract with Screen4 for COVID-19 antibody laboratory-based testing service
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has signed a contract with Screen4 Ltd ("Screen4") to provide a testing service using the Mologic ELISA1 antibody test for COVID-19 from the Company's in-house testing laboratory in Littleport, Cambridgeshire.
This follows the launch of the COVID-19 antibody testing service, as announced on 26 January 2021. The contract is for an initial term of three years.
Screen4 is a leading provider of COVID-19 testing services and diagnostic testing services to the aviation, petrochemical, occupational health and consumer markets in the UK and across the Middle east and Far East regions. Screen4 is an Approved Provider under the UK Government General testing and 'Test to Release' Scheme in the UK.
Colin King, CEO of Omega, commented: "Following on from setting up and launching our in-house testing service that utilises the Mologic COVID-19 IgG ELISA, I am pleased to be working with Screen4 as our first customer. Screen4 provide a synergistic approach involving health assessment and patient support to their clients."
David Grouse, Managing Director of Screen4, commented: "We are delighted to be involved with Omega Diagnostics on this project. Omega are at the forefront in the development of vital testing technologies to help fight the Covid-19 virus. We will be supporting them through the distribution of their latest product - the COVID-19 ELISA Antibody testing service. The simple, usable nature of this product, particularly with regards to a properly CE marked self-collection sample kit for Home Use, is a major step forward in helping people understand their current status with regards to the virus."
1 ELISA (Enzyme Linked Immuno-Sorbent Assay) tests are one of the most tested and proven laboratory technologies used by the global diagnostic industry and remain the principal reference point from which rapid diagnostics are coordinated, especially serological tests, including tests for COVID-19.
Perky all of a sudden . Up 10%
words of Nick Gibb ( Minister ) "And the first three tests will be in school so the students, who will do it themselves actually, will learn how to do it effectively and then testing kits will be sent home."
Abdx on a roll up 10% today
So we know why sells at 91p today at least . Onwards and Upwards !
and miss out on lots more , get lost loser !
and people sell ????
No wonder most people trading on Aim never make any money !
nothing sinister in that , I have been in a similar position before. Requests go in individually, they get approved and signed off in bulk to minimise the SP impact , rather than constant drip drip
2 more 250k buys popped up from 16.25 yesterday
Exactly , still can't buy on IG , only sell
So they are in Cahoots to let the bigger players in
Han***k press conference this pm
Surescreen get their order , us next once TT done ?
https://www.gov.uk/government/news/british-manufacturer-surescreen-diagnostics-to-supply-20-million-rapid-lateral-flow